Empathy is the root of dignity for patients, and healthcare providers need to consciously adjust their communication styles to demonstrate that empathy, according to Melissa Thompson, MBA, healthcare strategist, patient, and self-advocate. Some examples include not discussing the patient without including them and using inclusive language that brings the patient and provider together.
Empathy is the root of dignity for patients, and healthcare providers need to consciously adjust their communication styles to demonstrate that empathy, according to Melissa Thompson, MBA, healthcare strategist, patient, and self-advocate. Some examples include not discussing the patient without including them and using inclusive language that brings the patient and provider together.
Transcript (slightly modified)
How can clinicians ensure that they are providing patients with dignity? What does dignity mean to you?
Empathy’s rooted in communication, and unfortunately the healthcare system I think, elitism is baked into communication. We make calls, and nurses call up to physicians and they call down to housekeeping, and that communication trickles down to the patient. Having conversations around patients about them without including them when they’re in the same room makes us feel alienated.
Also, my oncologist is wonderful. When we talk, she sits across from me and she’s never taking notes, she’s not on a computer, she’s looking at me. And she never says “we.” She doesn’t say “we believe,” she says “I believe” or “I think.” When she says “we,” she kind of puts a verbal wedge between myself and her as the institution. When she says “I” and “you” and “me” and “we” meaning her and I, it’s really an act of empathy.
Empathy’s a verb in healthcare; empathy, I think, is the root of dignity.
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Sarcoma Care: Biomarker Advancements Shape the Future
October 24th 2024At the regional Institute for Value-Based Medicine® event in Boston, Vinayak Venkataraman, MD, medical oncologist at Dana-Farber Cancer Institute and Harvard Medical School, was a panelist for the discussion, “Recent Advancements in Identifying Predictive Biomarkers for Sarcomas."
Read More
Recognizing Symptoms of Myeloproliferative Neoplasms and Clinical Trial Challenges
October 24th 2024There can be a delay in diagnosis of myeloproliferative neoplasms as the symptoms of the diseases can be variable and common, such as fatigue, migraines, and difficulty concentrating, explained Ruben Mesa, MD, of Atrium Health.
Read More